Circulating biomarkers predictive of tumor response to cancer immunotherapy. Lee Ernest Y et al. Expert review of molecular diagnostics 2019 19(10) 895-904

Hot Topics of the Day|PHGKB


Last Posted: Jul 10, 2020

---

• Circulating biomarkers predictive of tumor response to cancer immunotherapy.
  Lee Ernest Y et al. Expert review of molecular diagnostics 2019 19(10) 895-904
• Genomic scoring to determine clinical benefit of immunotherapy by targeted sequencing.
  Kim Hong Sook et al. European journal of cancer (Oxford, England : 1990) 2019 12065-74
• A New FDA Approval Furthers the Role of Genomics in Cancer Care
  NCI Director blog, July 8, 2020
• Innovative Precision Gene-Editing Tools in Personalized Cancer Medicine.
  Dai Xiaofeng et al. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2020 Jun 7(12) 1902552
• Molecular matching and treatment strategies for advanced stage lung cancer at Dartmouth-Hitchcock Medical Center: A three-year review of a Molecular Tumor Board.
  Bernhardt Erica B et al. Practical laboratory medicine 2020 Aug 21e00174
• Association of Immune Checkpoint Inhibitor Therapy With Survival in Patients With Cancers With MUC16 Variants
  Y Yu, et al, JAMA Network Open, June 12, 2020
• Imaging-Based Prediction of Molecular Therapy Targets in NSCLC by Radiogenomics and AI Approaches: A Systematic Review.
  Ninatti Gaia et al. Diagnostics (Basel, Switzerland) 2020 May 10(6)
• MHC-I genotype and tumor mutational burden predict response to immunotherapy
  AM Goodman et al, Genome Medicine, May 19, 2020
• The Impact of Whole Genome Data on Therapeutic Decision-Making in Metastatic Prostate Cancer: A Retrospective Analysis.
  Crumbaker Megan et al. Cancers 2020 May 12(5)
• Development and validation of a five-immune gene prognostic risk model in colon cancer.
  Chen Haitao et al. BMC cancer 2020 May 20(1) 395

more